News from grifols A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 15, 2021, 09:00 ET Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived medicines with a track record of more than 100...

Apr 09, 2021, 10:30 ET Grifols 2020 Annual Report on Form 20-F filed with the SEC on April 9, 2021

Grifols, S.A. ("Grifols") (MCE: GRF), (MCE: GRF.P) and (NASDAQ: GRFS) announced that it has filed its 2020 Annual Report on Form 20-F with the United ...

Mar 22, 2021, 09:00 ET Grifols installs first-ever DG Reader Net analyzer in North America

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived therapies and leader in the development of...

Feb 23, 2021, 09:00 ET Grifols PharmacyKeeper ranked No. 1 as 'Best in KLAS' for fifth consecutive year

Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for...

Nov 16, 2020, 09:43 ET The Dow Jones Sustainability Index recognizes Grifols as one of the world's most sustainable companies

Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a global healthcare company and one of the world's leading producers of plasma-derived medicines with ...

Oct 09, 2020, 06:23 ET Grifols' anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of therapies with plasma-derived proteins with a track record of...

Sep 07, 2020, 02:50 ET Grifols to acquire Alkahest to enhance discovery research and development to identify innovative therapies for age-related diseases based upon an understanding of the human plasma proteome

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...

Jul 23, 2020, 08:00 ET Grifols acquires 10% stake in Bloodbuy, cloud-based marketplace for blood products

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...

Jul 20, 2020, 02:39 ET Grifols to acquire Green Cross plasma fractionation facility in Montreal and a plasma collection organization in the U.S. for US$460 million

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and one of world's top producers of plasma-derived medicines, today...

Apr 28, 2020, 09:00 ET Grifols launches new 3-mL (900-IU) vial for high-potency HyperRAB® (rabies immune globulin [human])

Grifols (MCE:GRF, MCE:GRF.P NASDAQ:GRFS), a leading global producer of plasma-derived medicines, today announced the launch of a new 3-mL (900-IU)...

Apr 20, 2020, 09:00 ET People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company with a track record of more than 100 years and a recognized leader in the...

Feb 13, 2020, 09:00 ET Grifols PharmacyKeeper ranked No. 1 in KLAS rating, extends category leadership

Grifols (MCE:GRF, MCE:GRF.P NASDAQ:GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for...

Dec 12, 2019, 09:24 ET Grifols launches XEMBIFY® (immune globulin subcutaneous human-klhw) 20%, a new Primary Immunodeficiency treatment

Grifols (MCE:GRF, MCE:GRF.P NASDAQ:GRFS), a leading global producer of plasma-derived medicines, today announced the launch of its latest...

Dec 06, 2019, 15:42 ET Grifols presents its latest Alzheimer's clinical trial data

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today concluded more than a year of encouraging...

Dec 05, 2019, 10:26 ET Grifols Streamlines Hospital Pharmacy Operations With New KIRO Fill® Technology and PharmacyKeeper Enhancements

Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for...

Dec 02, 2019, 09:17 ET Grifols to present latest Alzheimer's clinical trial results

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines, will present the final and complete clinical,...

Nov 07, 2019, 10:00 ET Grifols introduces AlphaID™, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD

Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of innovative...

Nov 07, 2019, 07:20 ET A Grifols se expande na América Latina com o início da produção na nova fábrica no Brasil

A Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), uma produtora líder global de medicamentos derivados do plasma e soluções para transfusão, anunciou ...

Jul 16, 2019, 02:39 ET Grifols presents additional encouraging Alzheimer's trial results at AAIC

The Grifols Clinical Research team, led by Dr. Antonio Páez, today presented additional results of its AMBAR (Alzheimer Management by Albumin...

Jul 04, 2019, 11:51 ET Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

Grifols (MCE:GRF) (MCE:GRF.P) (NASDAQ: GRFS), a leading global producer of plasma-derived medicines, announced today that Xembify®, its new 20%...

Jul 03, 2019, 05:00 ET Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa

Grifols (MCE: GRF) (MCE: GRF.P) (NASDAQ: GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening...

Jun 19, 2019, 09:00 ET Grifols to launch plasma-protein-based bleeding-control solutions

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases,...

Apr 30, 2019, 06:00 ET Grifols Announces PharmacyKeeper Bidirectional Integration with Epic

Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines and provider of technologies and services for...

Apr 29, 2019, 12:00 ET Grifols Announces the Opening of its new Plasma Donor Center in Hinesville, Georgia

Grifols is pleased to announce the opening of a new Biotest plasma donor center located at 108 West Hendry Street, Hinesville, Georgia. The 11,000...

Apr 18, 2019, 09:00 ET Grifols US donor centers exceed 250,000 pounds of food collected

Grifols, one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announced that its U.S. network ...